I agree that this site is using cookies. You can find further informations here.
X
Tassinari, Elisa
114  results:
Search for persons X
?
1

TERT promoter mutations and the outcome of patients with ad..:

Mollica, Veronica ; Tassinari, Elisa ; Santoni, Matteo...
Pathology - Research and Practice.  253 (2024)  - p. 155008 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Integrating a quinone substructure into histone deacetylase..:

Guardigni, Melissa ; Greco, Giulia ; Poeta, Eleonora...
RSC Medicinal Chemistry.  15 (2024)  6 - p. 2045-2062 , 2024
Link: https://doi.org/10.1039/..
 
?
3

Human expressive movements: The boundary between health and..:

Pascarella, Angelo ; Gasparini, Sara ; Bellia, Angela...
Neuroscience & Biobehavioral Reviews.  161 (2024)  - p. 105639 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Appropriateness of Mini-Invasive Approaches for Nausea and ..:

Casadio, Chiara ; Tassinari, Elisa ; Carloni, Riccardo...
Case Reports in Oncology.  17 (2024)  1 - p. 270-276 , 2024
Link: https://doi.org/10.1159/..
 
?
5

Chromosome 3p gene alterations as biomarkers for immunocomb..:

Rosellini, Matteo ; Mollica, Veronica ; Marchetti, Andrea...
Pathology - Research and Practice.  254 (2024)  - p. 155142 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Tumor growth rate to assess therapy response to immune-base..:

Mollica, Veronica ; Rosellini, Matteo ; Brocchi, Stefano...
Expert Review of Precision Medicine and Drug Development.  9 (2024)  1 - p. 17-24 , 2024
Link: https://doi.org/10.1080/..
 
?
7

First in Class Dual Non-ATP-Competitive Glycogen Synthase K..:

Santini, Alan ; Tassinari, Elisa ; Poeta, Eleonora...
ACS Chemical Neuroscience.  15 (2024)  11 - p. 2099-2111 , 2024
Link: https://doi.org/10.1021/..
 
?
8

Re: Atezolizumab Plus Cabozantinib Versus Cabozantinib Mono..:

Rosellini, Matteo ; Tassinari, Elisa ; Marchetti, Andrea..
European Urology.  85 (2024)  1 - p. 97-98 , 2024
Link: https://doi.org/10.1016/..
 
?
9

Appropriateness of Mini-Invasive Approaches for Nausea and ..:

Casadio, Chiara ; Tassinari, Elisa ; Carloni, Riccardo...
info:eu-repo/semantics/altIdentifier/pmid/38362443.  , 2024
Link: https://hdl.handle.net/1..
 
?
10

Tumor growth rate to assess therapy response to immune-base..:

Mollica, Veronica ; Rosellini, Matteo ; Brocchi, Stefano...
info:eu-repo/semantics/altIdentifier/wos/WOS:001187065400001.  , 2024
Link: https://hdl.handle.net/1..
 
?
11

Safety issues in nutraceutical exploitation of Chlorella vu..:

Davani, Lara ; Tassinari, Elisa ; Chiaberge, Stefano...
Journal of Food Composition and Analysis.  123 (2023)  - p. 105568 , 2023
Link: https://doi.org/10.1016/..
 
?
12

From Monoamine Oxidase Inhibition to Antiproliferative Acti..:

Nordio, Giulia ; Piazzola, Francesco ; Cozza, Giorgio...
Molecules.  28 (2023)  17 - p. 6329 , 2023
Link: https://doi.org/10.3390/..
 
?
13

Complete remissions following immunotherapy or immuno-oncol..:

Santoni, Matteo ; Rizzo, Alessandro ; Kucharz, Jakub...
Cancer Immunology, Immunotherapy.  72 (2023)  6 - p. 1365-1379 , 2023
Link: https://doi.org/10.1007/..
 
?
14

The impact of ECOG performance status on efficacy of immuno..:

Mollica, Veronica ; Rizzo, Alessandro ; Marchetti, Andrea...
Clinical and Experimental Medicine.  23 (2023)  8 - p. 5039-5049 , 2023
Link: https://doi.org/10.1007/..
 
?
15

Metabolic pseudoprogression in a patient with metastatic KI..:

Tassinari, Elisa ; Conci, Nicole ; Battisti, Giacomo...
Frontiers in Oncology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
1-15